G282-7015 Screening compound: 7-cyclopropyl-N6-[(4-fluorophenyl)methyl]-6-methyl-8-oxo-N1-[2-(thiophen-2-yl)ethyl]-5H,6H,7H,8H-imidazo[1,5-a]pyrazine-1,6-dicarboxamide

G282-7015 Screening compound: 7-cyclopropyl-N6-[(4-fluorophenyl)methyl]-6-methyl-8-oxo-N1-[2-(thiophen-2-yl)ethyl]-5H,6H,7H,8H-imidazo[1,5-a]pyrazine-1,6-dicarboxamide
G282-7015 Screening compound: 7-cyclopropyl-N6-[(4-fluorophenyl)methyl]-6-methyl-8-oxo-N1-[2-(thiophen-2-yl)ethyl]-5H,6H,7H,8H-imidazo[1,5-a]pyrazine-1,6-dicarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G282-7015
7-cyclopropyl-N6-[(4-fluorophenyl)methyl]-6-methyl-8-oxo-N1-[2-(thiophen-2-yl)ethyl]-5H,6H,7H,8H-imidazo[1,5-a]pyrazine-1,6-dicarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G282-7015

Molecular Formula

C25H26FN5O3S (C25 H26 FN5 O3 S)

Compound Name

7-cyclopropyl-N6-[(4-fluorophenyl)methyl]-6-methyl-8-oxo-N1-[2-(thiophen-2-yl)ethyl]-5H,6H,7H,8H-imidazo[1,5-a]pyrazine-1,6-dicarboxamide

IUPAC name

7-cyclopropyl-N6-[(4-fluorophenyl)methyl]-6-methyl-8-oxo-N1-[2-(thiophen-2-yl)ethyl]-5H6H7H8H-imidazo[15-a]pyrazine-16-dicarboxamide

SMILES

CC(Cn1c2c(C(NCCc3cccs3)=O)nc1)(C(NCc(cc1)ccc1F)=O)N(C1CC1)C2=O

InChI

InChI=1S/C25H26FN5O3S/c1-25(24(34)28-13-16-4-6-17(26)7-5-16)14-30-15-29-20(21(30)23(33)31(25)18-8-9-18)22(32)27-11-10-19-3-2-12-35-19/h2-7,12,15,18H,8-11,13-14H2,1H3,(H,27,32)(H,28,34)/t25-/m0/s1

InChI Key

NALQCQQMONBKJU-VWLOTQADSA-N

MDL Number (MFCD)

MFCD27213147

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

495.58

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.996

Distribution Coefficient, logD

1.996

Water Solubility, LogSw

-2.62

Polar Surface Area

76.511

Acid Dissociation Constant (pKa)

11.91

Base Dissociation Constant (pKb)

0.89

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

36.00

G282-7015 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Cyclic Ugi PPI Library (9586 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Mimetics
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with G282-7015 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G282-7015?
Check Price and Availability of G282-7015, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G282-7015 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G282-7015
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G282-7015
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G282-7015 available by request